Blood cancer

Israeli researchers develop promising new blood cancer treatment

The technology has now been licensed to Immix BioPharma for further development and commercialization.  

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy